机构:[1]Beijing Neurosurgical Institute, Capital Medical University, Beijing, China研究所北京市神经外科研究所首都医科大学附属天坛医院[2]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China重点科室诊疗科室神经外科神经外科首都医科大学附属天坛医院[3]Department of Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China重点科室医技科室放射科放射科首都医科大学附属天坛医院[4]Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China医技科室核医学科首都医科大学附属天坛医院[5]Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China[6]Chinese Academy of Sciences, Institute of Automation, Beijing, China
Objective: We aimed to identify a radiomic signature to be used as a noninvasive biomarker of prognosis in patients with lower-grade gliomas (LGGs) and to reveal underlying biological processes through comprehensive radiogenomic investigation. Methods: We extracted 55 radiomic features from T2-weighted images of 233 patients with LGGs (training cohort: n = 85; validation cohort: n = 148). Univariate Cox regression and linear risk score formula were applied to generate a radiomic-based signature. Gene ontology analysis of highly expressed genes in the high-risk score group was conducted to establish a radiogenomic map. A nomogram was constructed for individualized survival prediction. Results: The six-feature radiomic signature stratified patients in the training cohort into low- or high-risk groups for overall survival (P = 0.0018). This result was successfully verified in the validation cohort (P = 0.0396). Radiogenomic analysis revealed that the prognostic radiomic signature was associated with hypoxia, angiogenesis, apoptosis, and cell proliferation. The nomogram resulted in high prognostic accuracy (C-index: 0.92, C-index: 0.70) and favorable calibration for individualized survival prediction in the training and validation cohorts. Conclusions: Our results suggest a great potential for the use of radiomic signature as a biological surrogate in providing prognostic information for patients with LGGs.
基金:
Beijing Natural Science FoundationBeijing Natural Science Foundation [7174295]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81601452]; Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2016ZZ-37]
第一作者机构:[1]Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[1]Beijing Neurosurgical Institute, Capital Medical University, Beijing, China[2]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China[5]Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China
推荐引用方式(GB/T 7714):
Qian Zenghui,Li Yiming,Sun Zhiyan,et al.Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction[J].AGING-US.2018,10(10):2884-2899.doi:10.18632/aging.101594.
APA:
Qian, Zenghui,Li, Yiming,Sun, Zhiyan,Fan, Xing,Xu, Kaibin...&Wang, Yinyan.(2018).Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction.AGING-US,10,(10)
MLA:
Qian, Zenghui,et al."Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction".AGING-US 10..10(2018):2884-2899